{"id":1305121,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-21","captureTimestamp":"2026-04-21T16:22:16.367000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54001.html","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) SGLT2 inhibitor use was not associated with an increased risk of severe UTI compared to use of DPP-4 inhibitors…","rawSnapshotUrl":"/api/snapshots/raw/1305121","browseUrl":"https://replay.healtharchive.ca/job-8/20260421162216/https://cihr-irsc.gc.ca/e/54001.html#ha_snapshot=1305121","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}